Global Biothrax (Anthrax Vaccine) Market Research Report 2020

Global Biothrax (Anthrax Vaccine) Market Research Report 2020

Table of Contents
1 Biothrax (Anthrax Vaccine) Market Overview
1.1 Product Overview and Scope of Biothrax (Anthrax Vaccine)
1.2 Biothrax (Anthrax Vaccine) Segment by Type
1.2.1 Global Biothrax (Anthrax Vaccine) Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 Live Vaccines
1.2.3 Cell Free PA Vaccines
1.3 Biothrax (Anthrax Vaccine) Segment by Application
1.3.1 Biothrax (Anthrax Vaccine) Sales Comparison by Application: 2020 VS 2026
1.3.2 Human Use
1.3.3 Animal Use
1.4 Global Biothrax (Anthrax Vaccine) Market Size Estimates and Forecasts
1.4.1 Global Biothrax (Anthrax Vaccine) Revenue 2015-2026
1.4.2 Global Biothrax (Anthrax Vaccine) Sales 2015-2026
1.4.3 Biothrax (Anthrax Vaccine) Market Size by Region: 2020 Versus 2026
1.5 Coronavirus Disease 2019 (Covid-19): Biothrax (Anthrax Vaccine) Industry Impact
1.5.1 How the Covid-19 is Affecting the Biothrax (Anthrax Vaccine) Industry
1.5.1.1 Biothrax (Anthrax Vaccine) Business Impact Assessment - Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19's Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Biothrax (Anthrax Vaccine) Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Biothrax (Anthrax Vaccine) Players to Combat Covid-19 Impact
2 Global Biothrax (Anthrax Vaccine) Market Competition by Manufacturers
2.1 Global Biothrax (Anthrax Vaccine) Sales Market Share by Manufacturers (2015-2020)
2.2 Global Biothrax (Anthrax Vaccine) Revenue Share by Manufacturers (2015-2020)
2.3 Global Biothrax (Anthrax Vaccine) Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Biothrax (Anthrax Vaccine) Manufacturing Sites, Area Served, Product Type
2.5 Biothrax (Anthrax Vaccine) Market Competitive Situation and Trends
2.5.1 Biothrax (Anthrax Vaccine) Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Biothrax (Anthrax Vaccine) Players (Opinion Leaders)
3 Biothrax (Anthrax Vaccine) Retrospective Market Scenario by Region
3.1 Global Biothrax (Anthrax Vaccine) Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Biothrax (Anthrax Vaccine) Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Biothrax (Anthrax Vaccine) Market Facts & Figures by Country
3.3.1 North America Biothrax (Anthrax Vaccine) Sales by Country
3.3.2 North America Biothrax (Anthrax Vaccine) Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Biothrax (Anthrax Vaccine) Market Facts & Figures by Country
3.4.1 Europe Biothrax (Anthrax Vaccine) Sales by Country
3.4.2 Europe Biothrax (Anthrax Vaccine) Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Biothrax (Anthrax Vaccine) Market Facts & Figures by Region
3.5.1 Asia Pacific Biothrax (Anthrax Vaccine) Sales by Region
3.5.2 Asia Pacific Biothrax (Anthrax Vaccine) Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Biothrax (Anthrax Vaccine) Market Facts & Figures by Country
3.6.1 Latin America Biothrax (Anthrax Vaccine) Sales by Country
3.6.2 Latin America Biothrax (Anthrax Vaccine) Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Biothrax (Anthrax Vaccine) Market Facts & Figures by Country
3.7.1 Middle East and Africa Biothrax (Anthrax Vaccine) Sales by Country
3.7.2 Middle East and Africa Biothrax (Anthrax Vaccine) Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Biothrax (Anthrax Vaccine) Historic Market Analysis by Type
4.1 Global Biothrax (Anthrax Vaccine) Sales Market Share by Type (2015-2020)
4.2 Global Biothrax (Anthrax Vaccine) Revenue Market Share by Type (2015-2020)
4.3 Global Biothrax (Anthrax Vaccine) Price Market Share by Type (2015-2020)
4.4 Global Biothrax (Anthrax Vaccine) Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Global Biothrax (Anthrax Vaccine) Historic Market Analysis by Application
5.1 Global Biothrax (Anthrax Vaccine) Sales Market Share by Application (2015-2020)
5.2 Global Biothrax (Anthrax Vaccine) Revenue Market Share by Application (2015-2020)
5.3 Global Biothrax (Anthrax Vaccine) Price by Application (2015-2020)
6 Company Profiles and Key Figures in Biothrax (Anthrax Vaccine) Business
6.1 Merial
6.1.1 Corporation Information
6.1.2 Merial Description, Business Overview and Total Revenue
6.1.3 Merial Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2015-2020)
6.1.4 Merial Products Offered
6.1.5 Merial Recent Development
6.2 Merck
6.2.1 Merck Corporation Information
6.2.2 Merck Description, Business Overview and Total Revenue
6.2.3 Merck Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2015-2020)
6.2.4 Merck Products Offered
6.2.5 Merck Recent Development
6.3 Zoetis
6.3.1 Zoetis Corporation Information
6.3.2 Zoetis Description, Business Overview and Total Revenue
6.3.3 Zoetis Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Zoetis Products Offered
6.3.5 Zoetis Recent Development
6.4 Bayer Sanidad Animal
6.4.1 Bayer Sanidad Animal Corporation Information
6.4.2 Bayer Sanidad Animal Description, Business Overview and Total Revenue
6.4.3 Bayer Sanidad Animal Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Bayer Sanidad Animal Products Offered
6.4.5 Bayer Sanidad Animal Recent Development
6.5 Colorado Serum
6.5.1 Colorado Serum Corporation Information
6.5.2 Colorado Serum Description, Business Overview and Total Revenue
6.5.3 Colorado Serum Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Colorado Serum Products Offered
6.5.5 Colorado Serum Recent Development
6.6 PharmAthene
6.6.1 PharmAthene Corporation Information
6.6.2 PharmAthene Description, Business Overview and Total Revenue
6.6.3 PharmAthene Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2015-2020)
6.6.4 PharmAthene Products Offered
6.6.5 PharmAthene Recent Development
6.7 Tiankang
6.6.1 Tiankang Corporation Information
6.6.2 Tiankang Description, Business Overview and Total Revenue
6.6.3 Tiankang Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Tiankang Products Offered
6.7.5 Tiankang Recent Development
6.8 Biogénesis-Bago
6.8.1 Biogénesis-Bago Corporation Information
6.8.2 Biogénesis-Bago Description, Business Overview and Total Revenue
6.8.3 Biogénesis-Bago Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2015-2020)
6.8.4 Biogénesis-Bago Products Offered
6.8.5 Biogénesis-Bago Recent Development
6.9 CAVAC
6.9.1 CAVAC Corporation Information
6.9.2 CAVAC Description, Business Overview and Total Revenue
6.9.3 CAVAC Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2015-2020)
6.9.4 CAVAC Products Offered
6.9.5 CAVAC Recent Development
6.10 Rosenbusch
6.10.1 Rosenbusch Corporation Information
6.10.2 Rosenbusch Description, Business Overview and Total Revenue
6.10.3 Rosenbusch Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2015-2020)
6.10.4 Rosenbusch Products Offered
6.10.5 Rosenbusch Recent Development
6.11 Agrovet
6.11.1 Agrovet Corporation Information
6.11.2 Agrovet Biothrax (Anthrax Vaccine) Description, Business Overview and Total Revenue
6.11.3 Agrovet Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2015-2020)
6.11.4 Agrovet Products Offered
6.11.5 Agrovet Recent Development
6.12 Vecol
6.12.1 Vecol Corporation Information
6.12.2 Vecol Biothrax (Anthrax Vaccine) Description, Business Overview and Total Revenue
6.12.3 Vecol Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2015-2020)
6.12.4 Vecol Products Offered
6.12.5 Vecol Recent Development
6.13 CVCRI
6.13.1 CVCRI Corporation Information
6.13.2 CVCRI Biothrax (Anthrax Vaccine) Description, Business Overview and Total Revenue
6.13.3 CVCRI Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2015-2020)
6.13.4 CVCRI Products Offered
6.13.5 CVCRI Recent Development
6.14 IVPM
6.14.1 IVPM Corporation Information
6.14.2 IVPM Biothrax (Anthrax Vaccine) Description, Business Overview and Total Revenue
6.14.3 IVPM Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2015-2020)
6.14.4 IVPM Products Offered
6.14.5 IVPM Recent Development
6.15 Prondil
6.15.1 Prondil Corporation Information
6.15.2 Prondil Biothrax (Anthrax Vaccine) Description, Business Overview and Total Revenue
6.15.3 Prondil Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2015-2020)
6.15.4 Prondil Products Offered
6.15.5 Prondil Recent Development
6.16 CDV
6.16.1 CDV Corporation Information
6.16.2 CDV Biothrax (Anthrax Vaccine) Description, Business Overview and Total Revenue
6.16.3 CDV Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2015-2020)
6.16.4 CDV Products Offered
6.16.5 CDV Recent Development
6.17 Indian Immunologicals
6.17.1 Indian Immunologicals Corporation Information
6.17.2 Indian Immunologicals Biothrax (Anthrax Vaccine) Description, Business Overview and Total Revenue
6.17.3 Indian Immunologicals Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2015-2020)
6.17.4 Indian Immunologicals Products Offered
6.17.5 Indian Immunologicals Recent Development
6.18 Botswana Vaccine Institute
6.18.1 Botswana Vaccine Institute Corporation Information
6.18.2 Botswana Vaccine Institute Biothrax (Anthrax Vaccine) Description, Business Overview and Total Revenue
6.18.3 Botswana Vaccine Institute Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2015-2020)
6.18.4 Botswana Vaccine Institute Products Offered
6.18.5 Botswana Vaccine Institute Recent Development
6.19 Ceva Santé Animale
6.19.1 Ceva Santé Animale Corporation Information
6.19.2 Ceva Santé Animale Biothrax (Anthrax Vaccine) Description, Business Overview and Total Revenue
6.19.3 Ceva Santé Animale Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2015-2020)
6.19.4 Ceva Santé Animale Products Offered
6.19.5 Ceva Santé Animale Recent Development
6.20 Intervac
6.20.1 Intervac Corporation Information
6.20.2 Intervac Biothrax (Anthrax Vaccine) Description, Business Overview and Total Revenue
6.20.3 Intervac Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2015-2020)
6.20.4 Intervac Products Offered
6.20.5 Intervac Recent Development
6.21 JOVAC
6.21.1 JOVAC Corporation Information
6.21.2 JOVAC Biothrax (Anthrax Vaccine) Description, Business Overview and Total Revenue
6.21.3 JOVAC Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2015-2020)
6.21.4 JOVAC Products Offered
6.21.5 JOVAC Recent Development
7 Biothrax (Anthrax Vaccine) Manufacturing Cost Analysis
7.1 Biothrax (Anthrax Vaccine) Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Biothrax (Anthrax Vaccine)
7.4 Biothrax (Anthrax Vaccine) Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Biothrax (Anthrax Vaccine) Distributors List
8.3 Biothrax (Anthrax Vaccine) Customers
9 Market Dynamics
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis
10 Global Market Forecast
10.1 Global Biothrax (Anthrax Vaccine) Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Biothrax (Anthrax Vaccine) by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Biothrax (Anthrax Vaccine) by Type (2021-2026)
10.2 Biothrax (Anthrax Vaccine) Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Biothrax (Anthrax Vaccine) by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Biothrax (Anthrax Vaccine) by Application (2021-2026)
10.3 Biothrax (Anthrax Vaccine) Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Biothrax (Anthrax Vaccine) by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Biothrax (Anthrax Vaccine) by Region (2021-2026)
10.4 North America Biothrax (Anthrax Vaccine) Estimates and Projections (2021-2026)
10.5 Europe Biothrax (Anthrax Vaccine) Estimates and Projections (2021-2026)
10.6 Asia Pacific Biothrax (Anthrax Vaccine) Estimates and Projections (2021-2026)
10.7 Latin America Biothrax (Anthrax Vaccine) Estimates and Projections (2021-2026)
10.8 Middle East and Africa Biothrax (Anthrax Vaccine) Estimates and Projections (2021-2026)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Biothrax (Anthrax Vaccine) Sales (K Units) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Biothrax (Anthrax Vaccine) Sales (K Units) Comparison by Application: 2020 VS 2026
Table 3. Global Biothrax (Anthrax Vaccine) Market Size by Type (K Units) (US$ Million) (2020 VS 2026)
Table 4. COVID-19 Impact Global Market: (Four Biothrax (Anthrax Vaccine) Market Size Forecast Scenarios)
Table 5. Opportunities and Trends for Biothrax (Anthrax Vaccine) Players in the COVID-19 Landscape
Table 6. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 7. Key Regions/Countries Measures against Covid-19 Impact
Table 8. Proposal for Biothrax (Anthrax Vaccine) Players to Combat Covid-19 Impact
Table 9. Global Key Biothrax (Anthrax Vaccine) Manufacturers Covered in This Study
Table 10. Global Biothrax (Anthrax Vaccine) Sales (K Units) by Manufacturers (2015-2020)
Table 11. Global Biothrax (Anthrax Vaccine) Sales Share by Manufacturers (2015-2020)
Table 12. Global Biothrax (Anthrax Vaccine) Revenue (Million USD) by Manufacturers (2015-2020)
Table 13. Global Biothrax (Anthrax Vaccine) Revenue Share by Manufacturers (2015-2020)
Table 14. Global Market Biothrax (Anthrax Vaccine) Average Price (US$/Unit) of Key Manufacturers (2015-2020)
Table 15. Manufacturers Biothrax (Anthrax Vaccine) Sales Sites and Area Served
Table 16. Manufacturers Biothrax (Anthrax Vaccine) Product Types
Table 17. Global Biothrax (Anthrax Vaccine) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 18. Global Biothrax (Anthrax Vaccine) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biothrax (Anthrax Vaccine) as of 2019)
Table 19.Manufacturers Mergers & Acquisitions, Expansion Plans
Table 20. Main Points Interviewed from Key Biothrax (Anthrax Vaccine) Players
Table 21. Global Biothrax (Anthrax Vaccine) Sales (K Units) by Region (2015-2020)
Table 22. Global Biothrax (Anthrax Vaccine) Sales Market Share by Region (2015-2020)
Table 23. Global Biothrax (Anthrax Vaccine) Revenue (Million US$) by Region (2015-2020)
Table 24. Global Biothrax (Anthrax Vaccine) Revenue Market Share by Region (2015-2020)
Table 25. North America Biothrax (Anthrax Vaccine) Sales by Country (2015-2020) (K Units)
Table 26. North America Biothrax (Anthrax Vaccine) Sales Market Share by Country (2015-2020)
Table 27. North America Biothrax (Anthrax Vaccine) Revenue by Country (2015-2020) (US$ Million)
Table 28. North America Biothrax (Anthrax Vaccine) Revenue Market Share by Country (2015-2020)
Table 29. Europe Biothrax (Anthrax Vaccine) Sales by Country (2015-2020) (K Units)
Table 30. Europe Biothrax (Anthrax Vaccine) Sales Market Share by Country (2015-2020)
Table 31. Europe Biothrax (Anthrax Vaccine) Revenue by Country (2015-2020) (US$ Million)
Table 32. Europe Biothrax (Anthrax Vaccine) Revenue Market Share by Country (2015-2020)
Table 33. Asia Pacific Biothrax (Anthrax Vaccine) Sales by Region (2015-2020) (K Units)
Table 34. Asia Pacific Biothrax (Anthrax Vaccine) Sales Market Share by Region (2015-2020)
Table 35. Asia Pacific Biothrax (Anthrax Vaccine) Revenue by Region (2015-2020) (US$ Million)
Table 36. Asia Pacific Biothrax (Anthrax Vaccine) Revenue Market Share by Region (2015-2020)
Table 37. Latin America Biothrax (Anthrax Vaccine) Sales by Country (2015-2020) (K Units)
Table 38. Latin America Biothrax (Anthrax Vaccine) Sales Market Share by Country (2015-2020)
Table 39. Latin America Biothrax (Anthrax Vaccine) Revenue by Country (2015-2020) (US$ Million)
Table 40. Latin America Biothrax (Anthrax Vaccine) Revenue Market Share by Country (2015-2020)
Table 41. Middle East and Africa Biothrax (Anthrax Vaccine) Sales by Country (2015-2020) (K Units)
Table 42. Middle East and Africa Biothrax (Anthrax Vaccine) Sales Market Share by Country (2015-2020)
Table 43. Middle East and Africa Biothrax (Anthrax Vaccine) Revenue by Country (2015-2020) (US$ Million)
Table 44. Middle East and Africa Biothrax (Anthrax Vaccine) Revenue Market Share by Country (2015-2020)
Table 45. Global Biothrax (Anthrax Vaccine) Sales (K Units) by Type (2015-2020)
Table 46. Global Biothrax (Anthrax Vaccine) Sales Share by Type (2015-2020)
Table 47. Global Biothrax (Anthrax Vaccine) Revenue (Million US$) by Type (2015-2020)
Table 48. Global Biothrax (Anthrax Vaccine) Revenue Share by Type (2015-2020)
Table 49. Global Biothrax (Anthrax Vaccine) Price (US$/Unit) by Type (2015-2020)
Table 50. Global Biothrax (Anthrax Vaccine) Sales (K Units) by Application (2015-2020)
Table 51. Global Biothrax (Anthrax Vaccine) Sales Market Share by Application (2015-2020)
Table 52. Global Biothrax (Anthrax Vaccine) Sales Growth Rate by Application (2015-2020)
Table 53. Merial Biothrax (Anthrax Vaccine) Corporation Information
Table 54. Merial Description and Business Overview
Table 55. Merial Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 56. Merial Main Product
Table 57. Merial Recent Development
Table 58. Merck Biothrax (Anthrax Vaccine) Corporation Information
Table 59. Merck Corporation Information
Table 60. Merck Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 61. Merck Main Product
Table 62. Merck Recent Development
Table 63. Zoetis Biothrax (Anthrax Vaccine) Corporation Information
Table 64. Zoetis Corporation Information
Table 65. Zoetis Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 66. Zoetis Main Product
Table 67. Zoetis Recent Development
Table 68. Bayer Sanidad Animal Biothrax (Anthrax Vaccine) Corporation Information
Table 69. Bayer Sanidad Animal Corporation Information
Table 70. Bayer Sanidad Animal Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 71. Bayer Sanidad Animal Main Product
Table 72. Bayer Sanidad Animal Recent Development
Table 73. Colorado Serum Biothrax (Anthrax Vaccine) Corporation Information
Table 74. Colorado Serum Corporation Information
Table 75. Colorado Serum Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 76. Colorado Serum Main Product
Table 77. Colorado Serum Recent Development
Table 78. PharmAthene Biothrax (Anthrax Vaccine) Corporation Information
Table 79. PharmAthene Corporation Information
Table 80. PharmAthene Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 81. PharmAthene Main Product
Table 82. PharmAthene Recent Development
Table 83. Tiankang Biothrax (Anthrax Vaccine) Corporation Information
Table 84. Tiankang Corporation Information
Table 85. Tiankang Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 86. Tiankang Main Product
Table 87. Tiankang Recent Development
Table 88. Biogénesis-Bago Biothrax (Anthrax Vaccine) Corporation Information
Table 89. Biogénesis-Bago Corporation Information
Table 90. Biogénesis-Bago Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 91. Biogénesis-Bago Main Product
Table 92. Biogénesis-Bago Recent Development
Table 93. CAVAC Biothrax (Anthrax Vaccine) Corporation Information
Table 94. CAVAC Corporation Information
Table 95. CAVAC Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 96. CAVAC Main Product
Table 97. CAVAC Recent Development
Table 98. Rosenbusch Biothrax (Anthrax Vaccine) Corporation Information
Table 99. Rosenbusch Corporation Information
Table 100. Rosenbusch Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 101. Rosenbusch Main Product
Table 102. Rosenbusch Recent Development
Table 103. Agrovet Biothrax (Anthrax Vaccine) Corporation Information
Table 104. Agrovet Corporation Information
Table 105. Agrovet Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 106. Agrovet Main Product
Table 107. Agrovet Recent Development
Table 108. Vecol Biothrax (Anthrax Vaccine) Corporation Information
Table 109. Vecol Corporation Information
Table 110. Vecol Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 111. Vecol Main Product
Table 112. Vecol Recent Development
Table 113. CVCRI Biothrax (Anthrax Vaccine) Corporation Information
Table 114. CVCRI Corporation Information
Table 115. CVCRI Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 116. CVCRI Main Product
Table 117. CVCRI Recent Development
Table 118. IVPM Biothrax (Anthrax Vaccine) Corporation Information
Table 119. IVPM Corporation Information
Table 120. IVPM Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 121. IVPM Main Product
Table 122. IVPM Recent Development
Table 123. Prondil Biothrax (Anthrax Vaccine) Corporation Information
Table 124. Prondil Corporation Information
Table 125. Prondil Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 126. Prondil Main Product
Table 127. Prondil Recent Development
Table 128. CDV Biothrax (Anthrax Vaccine) Corporation Information
Table 129. CDV Corporation Information
Table 130. CDV Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 131. CDV Main Product
Table 132. CDV Recent Development
Table 133. Indian Immunologicals Biothrax (Anthrax Vaccine) Corporation Information
Table 134. Indian Immunologicals Corporation Information
Table 135. Indian Immunologicals Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 136. Indian Immunologicals Main Product
Table 137. Indian Immunologicals Recent Development
Table 138. Botswana Vaccine Institute Biothrax (Anthrax Vaccine) Corporation Information
Table 139. Botswana Vaccine Institute Corporation Information
Table 140. Botswana Vaccine Institute Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 141. Botswana Vaccine Institute Main Product
Table 142. Botswana Vaccine Institute Recent Development
Table 143. Ceva Santé Animale Biothrax (Anthrax Vaccine) Corporation Information
Table 144. Ceva Santé Animale Corporation Information
Table 145. Ceva Santé Animale Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 146. Ceva Santé Animale Main Product
Table 147. Ceva Santé Animale Recent Development
Table 148. Intervac Biothrax (Anthrax Vaccine) Corporation Information
Table 149. Intervac Corporation Information
Table 150. Intervac Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 151. Intervac Main Product
Table 152. Intervac Recent Development
Table 153. JOVAC Biothrax (Anthrax Vaccine) Corporation Information
Table 154. JOVAC Corporation Information
Table 155. JOVAC Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 156. JOVAC Main Product
Table 157. JOVAC Recent Development
Table 158. Sales Base and Market Concentration Rate of Raw Material
Table 159. Key Suppliers of Raw Materials
Table 160. Biothrax (Anthrax Vaccine) Distributors List
Table 161. Biothrax (Anthrax Vaccine) Customers List
Table 162. Market Key Trends
Table 163. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 164. Key Challenges
Table 165. Global Biothrax (Anthrax Vaccine) Sales (K Units) Forecast by Type (2021-2026)
Table 166. Global Biothrax (Anthrax Vaccine) Sales Market Share Forecast by Type (2021-2026)
Table 167. Global Biothrax (Anthrax Vaccine) Revenue (Million US$) Forecast by Type (2021-2026)
Table 168. Global Biothrax (Anthrax Vaccine) Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 169. Global Biothrax (Anthrax Vaccine) Sales (K Units) Forecast by Application (2021-2026)
Table 170. Global Biothrax (Anthrax Vaccine) Revenue (Million US$) Forecast by Application (2021-2026)
Table 171. Global Biothrax (Anthrax Vaccine) Sales (K Units) Forecast by Region (2021-2026)
Table 172. Global Biothrax (Anthrax Vaccine) Sales Market Share Forecast by Region (2021-2026)
Table 173. Global Biothrax (Anthrax Vaccine) Revenue Forecast by Region (2021-2026) (US$ Million)
Table 174. Global Biothrax (Anthrax Vaccine) Revenue Market Share Forecast by Region (2021-2026)
Table 175. Research Programs/Design for This Report
Table 176. Key Data Information from Secondary Sources
Table 177. Key Data Information from Primary Sources
List of Figures
Figure 1. Picture of Biothrax (Anthrax Vaccine)
Figure 2. Global Biothrax (Anthrax Vaccine) Sales Market Share by Type: 2020 VS 2026
Figure 3. Live Vaccines Product Picture
Figure 4. Cell Free PA Vaccines Product Picture
Figure 5. Global Biothrax (Anthrax Vaccine) Consumption Market Share by Application: 2020 VS 2026
Figure 6. Human Use
Figure 7. Animal Use
Figure 8. Global Biothrax (Anthrax Vaccine) Market Size 2015-2026 (US$ Million)
Figure 9. Global Biothrax (Anthrax Vaccine) Sales Capacity (K Units) (2015-2026)
Figure 10. Global Biothrax (Anthrax Vaccine) Market Size Market Share by Region: 2020 Versus 2026
Figure 11. Biothrax (Anthrax Vaccine) Sales Share by Manufacturers in 2020
Figure 12. Global Biothrax (Anthrax Vaccine) Revenue Share by Manufacturers in 2019
Figure 13. The Global 5 and 10 Largest Players: Market Share by Biothrax (Anthrax Vaccine) Revenue in 2019
Figure 14. Biothrax (Anthrax Vaccine) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 15. Global Biothrax (Anthrax Vaccine) Sales Market Share by Region (2015-2020)
Figure 16. Global Biothrax (Anthrax Vaccine) Sales Market Share by Region in 2019
Figure 17. Global Biothrax (Anthrax Vaccine) Revenue Market Share by Region (2015-2020)
Figure 18. Global Biothrax (Anthrax Vaccine) Revenue Market Share by Region in 2019
Figure 19. North America Biothrax (Anthrax Vaccine) Sales Market Share by Country in 2019
Figure 20. North America Biothrax (Anthrax Vaccine) Revenue Market Share by Country in 2019
Figure 21. U.S. Biothrax (Anthrax Vaccine) Sales Growth Rate (2015-2020) (K Units)
Figure 22. U.S. Biothrax (Anthrax Vaccine) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 23. Canada Biothrax (Anthrax Vaccine) Sales Growth Rate (2015-2020) (K Units)
Figure 24. Canada Biothrax (Anthrax Vaccine) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 25. Europe Biothrax (Anthrax Vaccine) Sales Market Share by Country in 2019
Figure 26. Europe Biothrax (Anthrax Vaccine) Revenue Market Share by Country in 2019
Figure 27. Germany Biothrax (Anthrax Vaccine) Sales Growth Rate (2015-2020) (K Units)
Figure 28. Germany Biothrax (Anthrax Vaccine) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 29. France Biothrax (Anthrax Vaccine) Sales Growth Rate (2015-2020) (K Units)
Figure 30. France Biothrax (Anthrax Vaccine) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 31. U.K. Biothrax (Anthrax Vaccine) Sales Growth Rate (2015-2020) (K Units)
Figure 32. U.K. Biothrax (Anthrax Vaccine) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 33. Italy Biothrax (Anthrax Vaccine) Sales Growth Rate (2015-2020) (K Units)
Figure 34. Italy Biothrax (Anthrax Vaccine) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Russia Biothrax (Anthrax Vaccine) Sales Growth Rate (2015-2020) (K Units)
Figure 36. Russia Biothrax (Anthrax Vaccine) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Asia Pacific Biothrax (Anthrax Vaccine) Sales Market Share by Region in 2019
Figure 38. Asia Pacific Biothrax (Anthrax Vaccine) Revenue Market Share by Region in 2019
Figure 39. China Biothrax (Anthrax Vaccine) Sales Growth Rate (2015-2020) (K Units)
Figure 40. China Biothrax (Anthrax Vaccine) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. Japan Biothrax (Anthrax Vaccine) Sales Growth Rate (2015-2020) (K Units)
Figure 42. Japan Biothrax (Anthrax Vaccine) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 43. South Korea Biothrax (Anthrax Vaccine) Sales Growth Rate (2015-2020) (K Units)
Figure 44. South Korea Biothrax (Anthrax Vaccine) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. India Biothrax (Anthrax Vaccine) Sales Growth Rate (2015-2020) (K Units)
Figure 46. India Biothrax (Anthrax Vaccine) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. Australia Biothrax (Anthrax Vaccine) Sales Growth Rate (2015-2020) (K Units)
Figure 48. Australia Biothrax (Anthrax Vaccine) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Taiwan Biothrax (Anthrax Vaccine) Sales Growth Rate (2015-2020) (K Units)
Figure 50. Taiwan Biothrax (Anthrax Vaccine) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Indonesia Biothrax (Anthrax Vaccine) Sales Growth Rate (2015-2020) (K Units)
Figure 52. Indonesia Biothrax (Anthrax Vaccine) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Thailand Biothrax (Anthrax Vaccine) Sales Growth Rate (2015-2020) (K Units)
Figure 54. Thailand Biothrax (Anthrax Vaccine) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Malaysia Biothrax (Anthrax Vaccine) Sales Growth Rate (2015-2020) (K Units)
Figure 56. Malaysia Biothrax (Anthrax Vaccine) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Philippines Biothrax (Anthrax Vaccine) Sales Growth Rate (2015-2020) (K Units)
Figure 58. Philippines Biothrax (Anthrax Vaccine) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Vietnam Biothrax (Anthrax Vaccine) Sales Growth Rate (2015-2020) (K Units)
Figure 60. Vietnam Biothrax (Anthrax Vaccine) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Latin America Biothrax (Anthrax Vaccine) Sales Market Share by Country in 2019
Figure 62. Latin America Biothrax (Anthrax Vaccine) Revenue Market Share by Country in 2019
Figure 63. Mexico Biothrax (Anthrax Vaccine) Sales Growth Rate (2015-2020) (K Units)
Figure 64. Mexico Biothrax (Anthrax Vaccine) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. Brazil Biothrax (Anthrax Vaccine) Sales Growth Rate (2015-2020) (K Units)
Figure 66. Brazil Biothrax (Anthrax Vaccine) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Argentina Biothrax (Anthrax Vaccine) Sales Growth Rate (2015-2020) (K Units)
Figure 68. Argentina Biothrax (Anthrax Vaccine) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Middle East and Africa Biothrax (Anthrax Vaccine) Sales Market Share by Country in 2019
Figure 70. Middle East and Africa Biothrax (Anthrax Vaccine) Revenue Market Share by Country in 2019
Figure 71. Turkey Biothrax (Anthrax Vaccine) Sales Growth Rate (2015-2020) (K Units)
Figure 72. Turkey Biothrax (Anthrax Vaccine) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Sau

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs